Cover Image

A Pharmacokinetic Analysis and Pharmacogenomic Study of 6-mercaptopurine

<p><strong>Background:</strong> The efficacy and safety of 6-mercaptopurine (6-MP) therapy rely on the concentration of its metabolites. The aim of the current study is the pharmacokinetic analysis of 6-MP and the detection of its metabolites as well as the role of Thiopurine S-met...

Full description

Saved in:

Bibliographic Details
Main Authors:	Vicha A (Author), Katsila T (Author), Giannopoulou E (Author), Leontari H (Author), El Mubarak M (Author), Gravia A (Author), Chondrou V (Author), Symeonidis A (Author), Patrinos GP (Author), Kalofonos HP (Author), Sivolapenko G (Author)
Format:	Book
Published:	International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications, 2015-05-23.
Subjects:	Research Article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow
by: Efstathia Giannopoulou, et al.
Published: (2019)

Whole Genome Sequencing in Pharmacogenomics
by: George P Patrinos, et al.
Published: (2015)

Effects of 6- Mercaptopurine on Salivary Glands in Rabbit
by: Alhan D Al-Moula, et al.
Published: (2012)

Cephalothin as a Carrier of 6-Mercaptopurine for Targeting Cancer Tissues
by: Mohammad H. Mohammad, et al.
Published: (2017)

Cephalothin as a Carrier of 6-Mercaptopurine for Targeting Cancer Tissues
by: Mohammad H. Mohammad, et al.
Published: (2017)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
by: George P. Patrinos, et al.
Published: (2023)

Toxicity evaluation of 6-mercaptopurine-Chitosan nanoparticles in rats
by: Prem Kumar Govindappa, et al.
Published: (2020)

Adoption of Pharmacogenomic Testing: A Marketing Perspective
by: Margarita-Ioanna Koufaki, et al.
Published: (2021)

Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy
by: Zeina N. Al-Mahayri, et al.
Published: (2020)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
by: Francesco Sessa, et al.
Published: (2023)

Exploring the Enhanced Antiproliferative Activity of Turmeric Oil and 6-Mercaptopurine in a Combined Nano-Particulate System Formulation
by: Tarek A. Ahmed, et al.
Published: (2023)

Synthesis and Preliminary Anticancer Evaluation of 6-Mercaptopurine -Methotrexate Conjugate as Possible Mutual Prodrug
by: Asmaa S. Al-Darraji, et al.
Published: (2019)

Design and development of hydrogel nanoparticles for mercaptopurine
by: V Senthil, et al.
Published: (2010)

The Synthesis and Preliminary Anticancer Evaluation of 6-Mercaptopurine -Methotrexate Conjugate as Possible Mutual Prodrug
by: Asmaa Safwan Al-darraji, et al.
Published: (2019)

Do future healthcare professionals advocate for pharmacogenomics? A study on medical and health sciences undergraduate students
by: Hanan Al-Suhail, et al.
Published: (2024)

A Novel Text-Mining Approach for Retrieving Pharmacogenomics Associations From the Literature
by: Maria-Theodora Pandi, et al.
Published: (2020)

Azathioprine and 6-mercaptopurine-induced intrahepatic cholestasis of pregnancy: Case report and review of the literature
by: Maya Frank Wolf, et al.
Published: (2023)

Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
by: Dorniani D, et al.
Published: (2013)

Optimization and validation of an RP-HPLC method for the estimation of 6-mercaptopurine in bulk and pharmaceutical formulations
by: Vanita Somasekhar
Published: (2014)

Antiviral Potential of Azathioprine and Its Derivative 6- Mercaptopurine: A Narrative Literature Review
by: Carolina Rios-Usuga, et al.
Published: (2024)

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs
by: Wojciech Miltyk, et al.
Published: (2022)

Effect of maintenance therapy for childhood with acute lymphoblastic leukaemia by combination of methotrexate and 6-mercaptopurine on the liver.
by: Abid T. Firas, et al.
Published: (2005)

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children
by: Theodora eKatsila, et al.
Published: (2015)

Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics
by: Ibrahim El-Serafi, et al.
Published: (2024)

Severe recurrent nocturnal hypoglycemia during chemotherapy with 6-mercaptopurine in a child with acute lymphoblastic leukemia
by: Eun Mi Cho, et al.
Published: (2018)

Pharmacometabolomics informs viromics towards precision medicine
by: Aggeliki Balasopoulou, et al.
Published: (2016)

Profound Hypoglycemia and High Anion Gap Metabolic Acidosis in a Pediatric Leukemic Patient Receiving 6-Mercaptopurine
by: Molly O'Shea, et al.
Published: (2024)

Pharmacological evaluation of the protective effect of hydroalcoholic extract of walnut (Juglans regia L.) leaf on 6-mercaptopurine-induced hepatotoxicity in rats
by: Afaf H. Al-Nadaf, et al.
Published: (2024)

Loading cisplatin onto 6-mercaptopurine covalently modified MSNS: a nanomedicine strategy to improve the outcome of cisplatin therapy
by: Lv X, et al.
Published: (2016)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
by: Babayeva M, et al.
Published: (2020)

ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
by: Borhan Moradveisi, et al.
Published: (2019)

Quantification of 6-Mercaptopurine and Its Metabolites in Patients with Acute Lympoblastic Leukemia Using Dried Blood Spots and UPLC-MS/MS
by: Supandi Supandi, et al.
Published: (2018)

Genetic variants of genes involved in thiopurine metabolism pathway are associated with 6-mercaptopurine toxicity in pediatric acute lymphoblastic leukemia patients from Ethiopia
by: Awol Mekonnen Ali, et al.
Published: (2023)

Effects of TPMT, NUDT15, and ITPA Genetic Variants on 6-Mercaptopurine Toxicity for Pediatric Patients With Acute Lymphoblastic Leukemia in Yunnan of China
by: Xiaoyan Mao, et al.
Published: (2021)

Screening of Novel Pharmacogenetic Candidates for Mercaptopurine-Induced Toxicity in Patients With Acute Lymphoblastic Leukemia
by: Minyuan Cao, et al.
Published: (2020)

Impact of the homozygous mutation in Nudix hydrolase 15 on myelosuppression with 6-mercaptopurine in a European girl with acute lymphoblastic leukemia: a case report
by: Laura Elena Pineda-Lancheros, et al.
Published: (2023)

Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
by: Yeonhong Lee, et al.
Published: (2022)

Clinical pharmacists' knowledge, attitude, perception, and beliefs about the role of pharmacogenetic testing for genes polymorphisms when prescribing mercaptopurine
by: Norah O. Abanmy, et al.
Published: (2024)

Pharmacogenomics In Pharmacy Practice: Current Perspectives
by: Elewa H, et al.
Published: (2019)

Editorial: NSAIDs Pharmacogenomics
by: José A. G. Agúndez, et al.
Published: (2021)